| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/02/2013 | CN101522705B Antibacterial and antiviral peptides from actinomadura namibiensis |
| 10/01/2013 | US8546530 Process for the manufacture of persilylated peptides |
| 10/01/2013 | US8546529 Injectable bone regeneration gel containing bone formation enhancing peptide |
| 10/01/2013 | US8546528 Skin or hair binding peptides |
| 10/01/2013 | US8546526 Peptide or peptidomimetic compounds containing the Arg-Gly-Asp sequence: new class of diagnostic noninvasive tracers as suitable tools for integrin alpha v beta 3-targeted therapy and imaging; antiproliferation agents; angiogenesis inhibititors; antitumor agents; anticarcinogenic agents; kits |
| 10/01/2013 | US8546339 Soothing cosmetic or pharmaceutical composition comprising a peptide which activates HMG-CoA reductase |
| 10/01/2013 | US8546323 Thrombospondin-1 derived peptides and treatment methods |
| 10/01/2013 | US8546086 Use of neuregulin-β as an indicator and/or target |
| 10/01/2013 | US8546072 Substrate for assaying β-glucan and/or endotoxin and assay method |
| 10/01/2013 | CA2678967C Rna targeting compounds and methods for making and using same |
| 10/01/2013 | CA2502304C Phenolic binding peptides |
| 09/26/2013 | WO2013142229A1 Designing novel peptides for inducing fibronectin matrix assembly |
| 09/26/2013 | WO2013142200A1 Peptide with gold binding and egfr receptor affinity and same attached to gold nanostructure |
| 09/26/2013 | WO2013141965A1 Tfpi inhibitors and methods of use |
| 09/26/2013 | WO2013141750A1 Synthetic peptides wtih a non-narcotic type of analgesic effect |
| 09/26/2013 | WO2013141716A1 Biomarkers |
| 09/26/2013 | WO2013140643A1 Carrier for intracellular delivery of functional protein |
| 09/26/2013 | WO2013140388A1 Peptides for management of lactation |
| 09/26/2013 | WO2013139993A1 Peptide-based f-actin affinity matrix |
| 09/26/2013 | WO2013139719A1 Native ligation method |
| 09/26/2013 | US20130252907 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell |
| 09/26/2013 | US20130252906 Compounds and methods for treating or preventing disease conditions associated with alpha-1-antitrypsin |
| 09/26/2013 | US20130252905 Plif multimeric peptides and uses thereof |
| 09/26/2013 | US20130252895 Peptides of syndecan-1 for inhibit angiogenesis |
| 09/26/2013 | US20130252892 Novel octapeptide compounds and therapeutic use thereof |
| 09/26/2013 | US20130252891 Therapeutically Active Alpha-MSH Analogues |
| 09/26/2013 | US20130252883 Macrocycles and Their Uses |
| 09/26/2013 | US20130252880 Dendrimeric Peptides, Pharmaceutical Compositions And Methods Of Using The same |
| 09/26/2013 | US20130251719 Bone marrow aplasia with haemorrhagic disease in calves caused by novel pathogen |
| 09/25/2013 | CN103328497A 环孢菌素类似物 Cyclosporin analogs |
| 09/25/2013 | CN103328496A Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 09/25/2013 | CN103319571A Nasopharyngeal carcinoma radiotherapy-sensitive polypeptide marker SPG03 and ELISA kit thereof |
| 09/25/2013 | CN103319570A Preparation method of bivalirudin |
| 09/25/2013 | CN103319569A High-throughput screening system and method of potential medicaments taking c-Cbl protein cyclic functional regions as target points |
| 09/25/2013 | CN102485748B Oligopeptides with targeting thrombolytic activity, preparation method thereof, and application thereof |
| 09/25/2013 | CN102485747B Oligopeptides with targeting thrombolytic activity, preparation method and application thereof |
| 09/25/2013 | CN102477077B Boc-Pro-Ala-Lys-Lys(Pro-Ala-Lys)-OCH2(CH2)nCH3, synthesis method and application thereof as thrombus dissolving agent |
| 09/25/2013 | CN102477074B Oligopeptide compound and preparation method and application thereof |
| 09/25/2013 | CN102477071B Pro-Ala-Lys-Lys(Pro-Ala-Lys)-Asp[OCH2(CH2)nCH3]-OCH2(CH2)nCH3, synthesis method and application thereof as thrombus dissolving agent |
| 09/25/2013 | CN102276695B Polypeptide with function of lowering blood pressure and application thereof |
| 09/25/2013 | CN101239190B Vitamin receptor binding drug delivery conjugates |
| 09/24/2013 | US8541670 Compositions and methods for inhibiting tumor cell growth |
| 09/24/2013 | US8541545 Stabilized melanocortin ligands |
| 09/24/2013 | US8541365 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 09/24/2013 | CA2658491C Membrane-translocating peptides |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/20/2013 | CA2771954A1 Pneumonia biomarkers |
| 09/19/2013 | WO2013137396A1 NOVEL INTEGRIN α9β1 LIGAND AND USES THEREOF |
| 09/19/2013 | WO2013137302A1 Lysine oligomer derivative and cartilage tissue marker made thereof |
| 09/19/2013 | WO2013136338A1 Modified kisspeptin peptides and uses thereof |
| 09/19/2013 | WO2013136078A1 Therapeutic use of p75ntr neurotrophin binding protein |
| 09/19/2013 | WO2013135748A1 Polypeptides binding to dll4 and uses thereof |
| 09/19/2013 | WO2013135747A1 Polypeptides binding to dll4 and uses thereof |
| 09/19/2013 | WO2013135359A1 Targeting aminoacid lipids |
| 09/19/2013 | US20130245100 Polynucleotide for use in treatment of influenza a virus induced diseases, encoding modified mx protein, said modified mx protein, and a transgenic animal expressing gene encoding modified mx protein |
| 09/19/2013 | US20130244949 Novel anticancer agents comprising peptides with cancer-specific toxicity |
| 09/19/2013 | US20130244947 Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
| 09/19/2013 | US20130244946 Compositions and methods for prevention and treatment of neurodegenerative diseases |
| 09/19/2013 | US20130244939 Novel peptides that bind to the erythropoietin receptor |
| 09/19/2013 | US20130244934 Vip fragments and methods of use |
| 09/19/2013 | US20130244930 Antifungal agents and uses thereof |
| 09/19/2013 | US20130244929 Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials |
| 09/19/2013 | US20130244928 Antimicrobial peptides and derived metapeptides |
| 09/19/2013 | US20130244925 Molecules mimicking an autoantibody idiotype and compositions containing same |
| 09/19/2013 | US20130243959 Method for manufacturing a gold core/insulator shell nanostructure using a novel peptide |
| 09/19/2013 | US20130243804 Peptide Sequences and Compositions |
| 09/19/2013 | US20130243802 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy |
| 09/19/2013 | US20130243711 Novel trpv1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same |
| 09/18/2013 | EP2638059A1 Dermatopontin-activating peptides and cosmetic compositions including same |
| 09/18/2013 | EP2638058A1 Enolase peptide conjugate vaccines against staphylococcus aureus |
| 09/18/2013 | EP2637682A1 Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds |
| 09/18/2013 | CN103314006A Novel angiotensin type 2 (at2) receptor agonists and uses thereof |
| 09/18/2013 | CN103314005A Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions |
| 09/18/2013 | CN103313723A Peptide |
| 09/18/2013 | CN103305473A Bluetongue virus serum 1 (BTV1) VP2 protein monoclonal antibody (BTV1-4B6), B-cell epitope polypeptide identified by BTV1-4B6 and application of BTV1-4B6 |
| 09/18/2013 | CN103305472A Bluetongue virus serum 1 (BTV1) VP2 protein monoclonal antibody (BTV1-3E8), B-cell epitope polypeptide identified by BTV1-3E8 and application of BTV1-3E8 |
| 09/18/2013 | CN103305471A Monoclonal antibody BTV8-VP2-4D9 resist ant to bluetongue virus serum 8 type VP2 protein, B-cell epitope peptide identified thereby and application |
| 09/18/2013 | CN103305470A Monoclonal antibody BTV8-VP2-3E11 resistant to bluetongue virus serum 8 type VP2 protein, B-cell epitope peptide identified thereby and application |
| 09/18/2013 | CN103304640A Method for extracting echinocandins compound from fermentation liquid |
| 09/18/2013 | CN103304639A Method for purifying desmopressin intermediates |
| 09/18/2013 | CN103304638A PD-L1 affinity peptide with anti-tumour activity and application for same |
| 09/18/2013 | CN103304637A Cell permeable peptide hPP3 and usage thereof |
| 09/18/2013 | CN103304636A Mycobacterium tuberculosis candidate antigen polypeptide and application thereof |
| 09/18/2013 | CN103304635A Application of cyclopeptide compound for preventing tumors and preparation method of compound |
| 09/18/2013 | CN103304634A Matrix metalloproteinase-2 polypeptide inhibitor and application |
| 09/18/2013 | CN103304633A Tubulin polymerizing agent polypeptides 1 and application thereof |
| 09/18/2013 | CN103304632A Tubulin polymerizing agent polypeptides 2 and application thereof |
| 09/18/2013 | CN103304631A Nonapeptide with anti-tumour activity |
| 09/18/2013 | CN103304630A GPCR active polypeptide in scorpion venom of Buthus martensii Karsch, and extracting separation and application thereof |
| 09/18/2013 | CN102731623B Murine original monoclonal antibody 3D8 identified hantaan virus glycoprotein neutralizing epitope peptide and application thereof |
| 09/18/2013 | CN102600453B Preparation method of colistin sulfate premixing agents |
| 09/18/2013 | CN102358751B Human fibrinogen-like protein 2 prothrombinase immunogenicity peptide and use thereof |
| 09/18/2013 | CN102206253B Actin depolymerizing factor epitope, actin depolymerizing factor antibody and use thereof |
| 09/18/2013 | CN102127150B Nestin portion polypeptide and application thereof |
| 09/18/2013 | CN101730708B Stitched polypeptides |
| 09/17/2013 | US8536304 Tumour-associated peptides that bind to MHC molecules |
| 09/17/2013 | US8536231 Methods for treating diabetic foot ulcers |
| 09/17/2013 | US8536136 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/17/2013 | US8536122 Acylated GLP-1 compounds |
| 09/17/2013 | US8536120 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |